If we were mislead by a CEO who has a public offering, and the fillings don't match the pump, (filings, shareholder letters, and tweets), then that would be cause for SEC intervention in my opinion. If the SEC were to get involved they would then match up the price per share during each pump and then assess damages... at least that is what has happened in the past on other OTC stocks that I had the misfortune of buying.

I am hoping that SB will come thru for us thou.